Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shunbin Xiong

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
BMC Cancer|March 17, 2019
Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancerChao Zhang, Min Mao, Xu Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2022
Omics analyses of a somatic <i>Trp53</i> breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signalingXiaojie Yu, Yun Zhang, Shunbin Xiong, et al.
Cancer Research Communications|July 12, 2024
p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional MediatorJoy M McDaniel, Rhiannon L Morrissey, Denada Dibra, et al.
NPJ Breast Cancer|December 12, 2025
Stromal fibroblastic mutant Trp53 promotes mammary tumor development via enhanced secretion of paracrine factorsBin Liu, Shunbin Xiong, Abie Williams-Villalobo, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 11, 2019
Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival EstimationXu Guo, Yao Xu, Xin Wang, et al.
Nature Communications|September 29, 2018
Somatic Trp53 mutations differentially drive breast cancer and evolution of metastasesYun Zhang, Shunbin Xiong, Bin Liu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 25, 2018
ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling PathwayYanqin Zhang, Qianghua Hu, Guixin Li, et al.
Cancer Research|March 23, 2022
Differential Gain-of-Function Activity of Three p53 Hotspot Mutants In VivoShunbin Xiong, Dhruv Chachad, Yun Zhang, et al.
Journal of Pineal Research|November 20, 2016
Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathwaysYue Gao, Xiangsheng Xiao, Changlin Zhang, et al.
Cancer Discovery|April 17, 2023
Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic ProgramJovanka Gencel-Augusto, Xiaoping Su, Yuan Qi, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
BMC Cancer|March 17, 2019
Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancerChao Zhang, Min Mao, Xu Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2022
Omics analyses of a somatic <i>Trp53</i> breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signalingXiaojie Yu, Yun Zhang, Shunbin Xiong, et al.
Cancer Research Communications|July 12, 2024
p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional MediatorJoy M McDaniel, Rhiannon L Morrissey, Denada Dibra, et al.
NPJ Breast Cancer|December 12, 2025
Stromal fibroblastic mutant Trp53 promotes mammary tumor development via enhanced secretion of paracrine factorsBin Liu, Shunbin Xiong, Abie Williams-Villalobo, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 11, 2019
Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival EstimationXu Guo, Yao Xu, Xin Wang, et al.
Nature Communications|September 29, 2018
Somatic Trp53 mutations differentially drive breast cancer and evolution of metastasesYun Zhang, Shunbin Xiong, Bin Liu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 25, 2018
ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling PathwayYanqin Zhang, Qianghua Hu, Guixin Li, et al.
Cancer Research|March 23, 2022
Differential Gain-of-Function Activity of Three p53 Hotspot Mutants In VivoShunbin Xiong, Dhruv Chachad, Yun Zhang, et al.
Journal of Pineal Research|November 20, 2016
Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathwaysYue Gao, Xiangsheng Xiao, Changlin Zhang, et al.
Cancer Discovery|April 17, 2023
Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic ProgramJovanka Gencel-Augusto, Xiaoping Su, Yuan Qi, et al.
Pageof 5